Olanzapine serum concentrations in psychiatric patients given standard doses : The influence of comedication
We recorded steady state serum concentrations of olanzapine in 56 psychiatric patients under routine conditions. Twenty-two patients (39%) underwent monotherapy; the rest received additional psychotropic drugs. Doses were given once daily in the evening, and serum olanzapine levels were measured 12...
Gespeichert in:
Veröffentlicht in: | Therapeutic drug monitoring 1999-02, Vol.21 (1), p.87-90 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 90 |
---|---|
container_issue | 1 |
container_start_page | 87 |
container_title | Therapeutic drug monitoring |
container_volume | 21 |
creator | OLESEN, O. V LINNET, K |
description | We recorded steady state serum concentrations of olanzapine in 56 psychiatric patients under routine conditions. Twenty-two patients (39%) underwent monotherapy; the rest received additional psychotropic drugs. Doses were given once daily in the evening, and serum olanzapine levels were measured 12 hours later. For the whole group, the concentration-to-dose ratio (C/D) varied 26-fold, with a median value of 4.8 (nmol/L)/(mg/24 hours), but 80% of the patients had C/D values within the range 2 to 10 (nmol/L)/(mg/24 hours). All but three patients received standard doses (5-20 mg/24 hours), of whom 80% had serum concentrations of olanzapine within the range 22 to 146 nmol/L. Patients comedicated with potential inhibitors of CYP2D6 and other drugs displayed a median C/D approximately 40% higher than the group undergoing monotherapy. Patients comedicated with carbamazepine had a median C/D 36% lower than that of the monotherapy group. Therefore, the serum concentration range (12-hour values) of 25 to 150 nmol/L can be expected for patients receiving a standard daily dose. |
doi_str_mv | 10.1097/00007691-199902000-00013 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00007691_199902000_00013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10051059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-b71f44599cac56ac2243cd6a58608fec30193a532f81198a2f19178f2caa9bc03</originalsourceid><addsrcrecordid>eNpNkFtLAzEQhYMotlb_guTB19XMJpsmvknxBoW-1Odlmk1sZJtdkq1Qf72x9RYYwsyccxg-Qiiwa2B6esPym0oNBWitWZm7IhfwIzKGisuCSy2OyZiB5IXglRyRs5TeskIoxk7JCBirgFV6TNpFi-EDex8sTTZuN9R0wdgwRBx8FxL1gfZpZ9Yeh-gN7fM4bxN99e820DRgaDA2tOmSTfSWLtc2W1y7tTmFdi7HbWzjzT7tnJw4bJO9-P4n5OXhfjl7KuaLx-fZ3bwwXLChWE3BCVFpbdBUEk1ZCm4aiZWSTDlrOAPNseKlUwBaYelAw1S50iDqlWF8QtQh18QupWhd3Ue_wbirgdVfAOsfgPUvwHoPMFsvD9Z-u8qH_zMeiGXB1bcAk8HWRQzGpz-dVKoUin8CWmB5_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Olanzapine serum concentrations in psychiatric patients given standard doses : The influence of comedication</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>OLESEN, O. V ; LINNET, K</creator><creatorcontrib>OLESEN, O. V ; LINNET, K</creatorcontrib><description>We recorded steady state serum concentrations of olanzapine in 56 psychiatric patients under routine conditions. Twenty-two patients (39%) underwent monotherapy; the rest received additional psychotropic drugs. Doses were given once daily in the evening, and serum olanzapine levels were measured 12 hours later. For the whole group, the concentration-to-dose ratio (C/D) varied 26-fold, with a median value of 4.8 (nmol/L)/(mg/24 hours), but 80% of the patients had C/D values within the range 2 to 10 (nmol/L)/(mg/24 hours). All but three patients received standard doses (5-20 mg/24 hours), of whom 80% had serum concentrations of olanzapine within the range 22 to 146 nmol/L. Patients comedicated with potential inhibitors of CYP2D6 and other drugs displayed a median C/D approximately 40% higher than the group undergoing monotherapy. Patients comedicated with carbamazepine had a median C/D 36% lower than that of the monotherapy group. Therefore, the serum concentration range (12-hour values) of 25 to 150 nmol/L can be expected for patients receiving a standard daily dose.</description><identifier>ISSN: 0163-4356</identifier><identifier>EISSN: 1536-3694</identifier><identifier>DOI: 10.1097/00007691-199902000-00013</identifier><identifier>PMID: 10051059</identifier><identifier>CODEN: TDMODV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adolescent ; Adult ; Analysis ; Antipsychotic Agents - blood ; Antipsychotic Agents - pharmacokinetics ; Benzodiazepines ; Biological and medical sciences ; Cytochrome P-450 CYP2D6 Inhibitors ; Drug Interactions ; Drug Monitoring ; Enzyme Inhibitors - pharmacology ; Female ; General pharmacology ; Humans ; Male ; Medical sciences ; Middle Aged ; Olanzapine ; Pharmacology. Drug treatments ; Pirenzepine - analogs & derivatives ; Pirenzepine - blood ; Pirenzepine - pharmacokinetics ; Psychotic Disorders - blood ; Psychotic Disorders - metabolism</subject><ispartof>Therapeutic drug monitoring, 1999-02, Vol.21 (1), p.87-90</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-b71f44599cac56ac2243cd6a58608fec30193a532f81198a2f19178f2caa9bc03</citedby><cites>FETCH-LOGICAL-c340t-b71f44599cac56ac2243cd6a58608fec30193a532f81198a2f19178f2caa9bc03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1688248$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10051059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OLESEN, O. V</creatorcontrib><creatorcontrib>LINNET, K</creatorcontrib><title>Olanzapine serum concentrations in psychiatric patients given standard doses : The influence of comedication</title><title>Therapeutic drug monitoring</title><addtitle>Ther Drug Monit</addtitle><description>We recorded steady state serum concentrations of olanzapine in 56 psychiatric patients under routine conditions. Twenty-two patients (39%) underwent monotherapy; the rest received additional psychotropic drugs. Doses were given once daily in the evening, and serum olanzapine levels were measured 12 hours later. For the whole group, the concentration-to-dose ratio (C/D) varied 26-fold, with a median value of 4.8 (nmol/L)/(mg/24 hours), but 80% of the patients had C/D values within the range 2 to 10 (nmol/L)/(mg/24 hours). All but three patients received standard doses (5-20 mg/24 hours), of whom 80% had serum concentrations of olanzapine within the range 22 to 146 nmol/L. Patients comedicated with potential inhibitors of CYP2D6 and other drugs displayed a median C/D approximately 40% higher than the group undergoing monotherapy. Patients comedicated with carbamazepine had a median C/D 36% lower than that of the monotherapy group. Therefore, the serum concentration range (12-hour values) of 25 to 150 nmol/L can be expected for patients receiving a standard daily dose.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Analysis</subject><subject>Antipsychotic Agents - blood</subject><subject>Antipsychotic Agents - pharmacokinetics</subject><subject>Benzodiazepines</subject><subject>Biological and medical sciences</subject><subject>Cytochrome P-450 CYP2D6 Inhibitors</subject><subject>Drug Interactions</subject><subject>Drug Monitoring</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Female</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Olanzapine</subject><subject>Pharmacology. Drug treatments</subject><subject>Pirenzepine - analogs & derivatives</subject><subject>Pirenzepine - blood</subject><subject>Pirenzepine - pharmacokinetics</subject><subject>Psychotic Disorders - blood</subject><subject>Psychotic Disorders - metabolism</subject><issn>0163-4356</issn><issn>1536-3694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkFtLAzEQhYMotlb_guTB19XMJpsmvknxBoW-1Odlmk1sZJtdkq1Qf72x9RYYwsyccxg-Qiiwa2B6esPym0oNBWitWZm7IhfwIzKGisuCSy2OyZiB5IXglRyRs5TeskIoxk7JCBirgFV6TNpFi-EDex8sTTZuN9R0wdgwRBx8FxL1gfZpZ9Yeh-gN7fM4bxN99e820DRgaDA2tOmSTfSWLtc2W1y7tTmFdi7HbWzjzT7tnJw4bJO9-P4n5OXhfjl7KuaLx-fZ3bwwXLChWE3BCVFpbdBUEk1ZCm4aiZWSTDlrOAPNseKlUwBaYelAw1S50iDqlWF8QtQh18QupWhd3Ue_wbirgdVfAOsfgPUvwHoPMFsvD9Z-u8qH_zMeiGXB1bcAk8HWRQzGpz-dVKoUin8CWmB5_A</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>OLESEN, O. V</creator><creator>LINNET, K</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19990201</creationdate><title>Olanzapine serum concentrations in psychiatric patients given standard doses : The influence of comedication</title><author>OLESEN, O. V ; LINNET, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-b71f44599cac56ac2243cd6a58608fec30193a532f81198a2f19178f2caa9bc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Analysis</topic><topic>Antipsychotic Agents - blood</topic><topic>Antipsychotic Agents - pharmacokinetics</topic><topic>Benzodiazepines</topic><topic>Biological and medical sciences</topic><topic>Cytochrome P-450 CYP2D6 Inhibitors</topic><topic>Drug Interactions</topic><topic>Drug Monitoring</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Female</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Olanzapine</topic><topic>Pharmacology. Drug treatments</topic><topic>Pirenzepine - analogs & derivatives</topic><topic>Pirenzepine - blood</topic><topic>Pirenzepine - pharmacokinetics</topic><topic>Psychotic Disorders - blood</topic><topic>Psychotic Disorders - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OLESEN, O. V</creatorcontrib><creatorcontrib>LINNET, K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Therapeutic drug monitoring</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OLESEN, O. V</au><au>LINNET, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Olanzapine serum concentrations in psychiatric patients given standard doses : The influence of comedication</atitle><jtitle>Therapeutic drug monitoring</jtitle><addtitle>Ther Drug Monit</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>21</volume><issue>1</issue><spage>87</spage><epage>90</epage><pages>87-90</pages><issn>0163-4356</issn><eissn>1536-3694</eissn><coden>TDMODV</coden><abstract>We recorded steady state serum concentrations of olanzapine in 56 psychiatric patients under routine conditions. Twenty-two patients (39%) underwent monotherapy; the rest received additional psychotropic drugs. Doses were given once daily in the evening, and serum olanzapine levels were measured 12 hours later. For the whole group, the concentration-to-dose ratio (C/D) varied 26-fold, with a median value of 4.8 (nmol/L)/(mg/24 hours), but 80% of the patients had C/D values within the range 2 to 10 (nmol/L)/(mg/24 hours). All but three patients received standard doses (5-20 mg/24 hours), of whom 80% had serum concentrations of olanzapine within the range 22 to 146 nmol/L. Patients comedicated with potential inhibitors of CYP2D6 and other drugs displayed a median C/D approximately 40% higher than the group undergoing monotherapy. Patients comedicated with carbamazepine had a median C/D 36% lower than that of the monotherapy group. Therefore, the serum concentration range (12-hour values) of 25 to 150 nmol/L can be expected for patients receiving a standard daily dose.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>10051059</pmid><doi>10.1097/00007691-199902000-00013</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-4356 |
ispartof | Therapeutic drug monitoring, 1999-02, Vol.21 (1), p.87-90 |
issn | 0163-4356 1536-3694 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00007691_199902000_00013 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adolescent Adult Analysis Antipsychotic Agents - blood Antipsychotic Agents - pharmacokinetics Benzodiazepines Biological and medical sciences Cytochrome P-450 CYP2D6 Inhibitors Drug Interactions Drug Monitoring Enzyme Inhibitors - pharmacology Female General pharmacology Humans Male Medical sciences Middle Aged Olanzapine Pharmacology. Drug treatments Pirenzepine - analogs & derivatives Pirenzepine - blood Pirenzepine - pharmacokinetics Psychotic Disorders - blood Psychotic Disorders - metabolism |
title | Olanzapine serum concentrations in psychiatric patients given standard doses : The influence of comedication |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A36%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Olanzapine%20serum%20concentrations%20in%20psychiatric%20patients%20given%20standard%20doses%20:%20The%20influence%20of%20comedication&rft.jtitle=Therapeutic%20drug%20monitoring&rft.au=OLESEN,%20O.%20V&rft.date=1999-02-01&rft.volume=21&rft.issue=1&rft.spage=87&rft.epage=90&rft.pages=87-90&rft.issn=0163-4356&rft.eissn=1536-3694&rft.coden=TDMODV&rft_id=info:doi/10.1097/00007691-199902000-00013&rft_dat=%3Cpubmed_cross%3E10051059%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10051059&rfr_iscdi=true |